Stock Information
Autolus Therapeutics PLC (AUTL)
Ticker Symbol: AUTL
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $375.26 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -1.0803
Revenue (TTM): $0.28 M
Dividend Yield: N/A%
ROE: -99.05%
Latest News
-
Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target
Thu, Apr 9, 2026 7:14 AM
-
Autolus Therapeutics plc (AUTL) Discusses Advances in B-cell Precursor Acute Lymphoblastic Leukemia Treatment and Clinical Trial Insights Transcript
Wed, Apr 8, 2026 6:16 PM
-
Autolus Therapeutics plc (AUTL) Discusses Advances in B-cell Precursor Acute Lymphoblastic Leukemia Treatment and Clinical Trial Insights - Slideshow
Wed, Apr 8, 2026 6:01 PM
-
Service Properties Trust, ConocoPhillips And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Mon, Apr 6, 2026 8:03 AM
Key Financials
Financial data not available
